People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Biotech / Pharma, Other Health Care, Pharmaceuticals, Biotechnology, Agtech / Foodtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PharmaCann Inc. | — | Biotech / Pharma | Series D+ | $509.0M | $413.5M | 2021 |
| InspireMD, Inc. | — | Other Health Care | Series C | $117.2M | $248.3M | 2012 |
| EyePoint Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $25.6M | $438.3M | 2018 |
| Cardiac Implants LLC | — | Biotechnology | Series A | $13.5M | $178.4M | 2022 |
| Offaly Good Foods, Inc. | — | Agtech / Foodtech | Pre-Seed | $250K | $3.7M | 2020 |
James Barry at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Barry on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Isaac Blech | 1 | 14 |
| Scott Jones | 1 | 11 |
| Michael Berman | 1 | 7 |
| Sol J. Barer | 1 | 6 |
| Sol Barer | 1 | 6 |
| John McCarthy | 1 | 6 |
| Asher Holzer | 1 | 4 |
| Patrick Barry | 1 | 4 |
| John Leja | 1 | 4 |
| Douglas Godshall | 1 | 4 |
| Michael Rogers | 1 | 3 |
| Kristine Peterson | 1 | 3 |
| Richard Geoffrion | 1 | 3 |
| John Lord | 1 | 3 |
| David Mazzo | 1 | 3 |
| Eli Bar | 1 | 3 |
| Ofir Paz | 1 | 2 |
| Daniel Roth | 1 | 2 |
| Alan Milinazzo | 1 | 2 |
| Paul Stuka | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.